Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024)
环境与职业医学 · 2024-01 · 41 (1) · 22-24
DOI: 10.11836/jeom23399 ↗Kurz gefasst
Fachartikel in der Zeitschrift 环境与职业医学, 2024-01. Verfasst von Ling MAO. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The most important revision of the Consensus of Chinese experts on pneumoconiosis treatment (2024) is to attach importance to antifibrotic treatment, and recommend tetrandrine and nintedanib for the treatment of silicosis and coal worker's pneumoconiosis, especially in patients with rapidly progressing silicosis. The second most important revision is a positive attitude towards lung transplantation which is recommended for patients with end-stage pneumoconiosis who do not respond to medically optimized conservative treatment as early as possible. In addition, new updates also include the addition of the application of metagenomic next-generation sequencing (mNGS) in pneumoconiosis with pulmonary infection, the diagnosis and treatment of pneumoconiosis with nontuberculous mycobacteriosis (NTM), and high-flow nasal cannula oxygen therapy (HFNC) in pneumoconiosis with respiratory failure therapies. The evidence and recommendations of the current version are assessed by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system.
Schlagwörter
Zitieren
APA
MAO, L. (2024). Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024). 环境与职业医学, 41(1), 22-24. https://doi.org/10.11836/jeom23399
Vancouver
MAO L. Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024). 环境与职业医学. 2024;41(1):22-24. doi:10.11836/jeom23399
BibTeX
@article{MAO2024,
author = {MAO, Ling},
title = {Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024)},
journal = {环境与职业医学},
year = {2024},
volume = {41},
number = {1},
pages = {22--24},
doi = {10.11836/jeom23399}
}
EUVIMED